Search

Changes in SKA2 gene associated with brain cell loss, more severe post-traumatic stress disorder (PTSD). Read more

ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, has announced that Joan W. Miller, MD, Chair of the Department of Ophthalmology, Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and...

The September 2015 issue of Eye Insights™, a clinical advisory newsletter published by Massachusetts Eye and Ear and Massachusetts General Hospital, is now available. This issue focuses on the Boston KPro, specifically on how to manage complications associated with implantation, postoperative...

Evangelos Gragoudas, MD, presented the J. Donald M. Gass lecture at the Retina Society Annual Meeting in Paris, France on October 8, 2015. A pioneer and a world authority on the diagnosis and management of intraocular tumors and retinal disease, Dr. Gragoudas and colleagues developed the use of...

BOSTON (October 19, 2015) -- Joan Whitten Miller, MD, Henry Willard Williams Professor of Ophthalmology and Chair of Ophthalmology at Harvard Medical School, and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, has been elected to membership in the prestigious...

On October 7 th and 8 th, Jason Comander, MD, PhD, and Leo Kim, MD, PhD, participated in the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program. This program allows scientists to meet with members of Congress to discuss the importance of vision research in the continuing...